Supplementary Table S8 from LM-101, an Anti-SIRPα Antibody, in Patients with Relapsed/Refractory Lymphoma and Advanced Head and Neck Cancer: An Open-Label, Multicenter, Phase I Trial

作者：Jun Cai, Baitian Zhao, Dongmei Ji, Fuling Zhou, Shenrui Bai, Xiaojie Fang, Man Nie, Bing Bai, Yuchen Zhang, Jin Li, Haoyuan Li, Yuan Li, Da Fei, Xia Qin, Crystal Qin, Shuiyu Zhao, Yi Xia, Qingqing Cai · 年份：2026 · DOI：10.1158/1078-0432.32675229 · 研究领域：Phagocytosis and Immune Regulation、Immune Cell Function and Interaction、Chronic Lymphocytic Leukemia Research

<p>Table S8 shows summary of LM-101 pharmacokinetic parameters.</p>